Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | CHKA | P35790 | 6/20 | 0.51 |
| ▸ | BCHE | P06276 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18775297 | 0.80 | MAOB (0.55) | BCHEACHEMAOBKIF11 | |
| SCHEMBL23373046 | 0.79 | KDM4E (0.67) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL18775301 | 0.79 | KDM4E (0.45) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL4407306 | 0.78 | CHKA (0.73) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL30826135 | 0.77 | BCHE (0.48) | ALDH1A1CHKABCHEACHEMAPT | |
| SCHEMBL18775294 | 0.77 | BCHE (0.78) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL13019482 | 0.75 | KIF11 (0.61) | ALDH1A1BCHEACHEMAOBKIF11 | |
| SCHEMBL1044865 | 0.75 | KIF11 (0.61) | ALDH1A1BCHEACHEMAOBKIF11 | |
| SCHEMBL15164180 | 0.75 | CHKA (0.83) | KDM4EALDH1A1RAB9ACHKABCHE | |
| SCHEMBL17110032 | 0.75 | KIF11 (0.61) | ALDH1A1BCHEACHEMAOBKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9969931-B2 | Electrochromic composition and electrochromic element | CANON KABUSHIKI KAISHA (JP) | 2018-05-15 | — | — | US | disclosed |
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | SCN11A, ECH1, H1-0 | KDM4E 1299/4885ALDH1A1 656/4885RAB9A 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.